211 related articles for article (PubMed ID: 28323276)
21. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
22. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
23. Capsule endoscopy in refractory celiac disease.
Daum S; Wahnschaffe U; Glasenapp R; Borchert M; Ullrich R; Zeitz M; Faiss S
Endoscopy; 2007 May; 39(5):455-8. PubMed ID: 17516353
[TBL] [Abstract][Full Text] [Related]
24. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
25. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR; Paski S; Ko CW; Rubio-Tapia A
Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
[TBL] [Abstract][Full Text] [Related]
26. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system.
Soderquist CR; Hsiao S; Mansukhani MM; Alobeid B; Green PH; Bhagat G
Hematol Oncol; 2020 Aug; 38(3):399-405. PubMed ID: 32010998
[TBL] [Abstract][Full Text] [Related]
27. Clinical Insignficance of Monoclonal T-Cell Populations and Duodenal Intraepithelial T-Cell Phenotypes in Celiac and Nonceliac Patients.
Celli R; Hui P; Triscott H; Bogardus S; Gibson J; Hwang M; Robert ME
Am J Surg Pathol; 2019 Feb; 43(2):151-160. PubMed ID: 30334829
[TBL] [Abstract][Full Text] [Related]
28. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
29. TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease.
Perfetti V; Brunetti L; Biagi F; Ciccocioppo R; Bianchi PI; Corazza GR
J Clin Gastroenterol; 2012 Sep; 46(8):675-9. PubMed ID: 22298086
[TBL] [Abstract][Full Text] [Related]
30. Small intestinal release mesalamine for the treatment of refractory celiac disease type I.
Jamma S; Leffler DA; Dennis M; Najarian RM; Schuppan DB; Sheth S; Kelly CP
J Clin Gastroenterol; 2011 Jan; 45(1):30-3. PubMed ID: 20871406
[TBL] [Abstract][Full Text] [Related]
31. Enteric-Release Budesonide May Be Useful in the Management of Non-Responsive Celiac Disease.
Therrien A; Silvester JA; Leonard MM; Leffler DA; Fasano A; Kelly CP
Dig Dis Sci; 2021 Jun; 66(6):1989-1997. PubMed ID: 32654085
[TBL] [Abstract][Full Text] [Related]
32. Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma.
Daum S; Hummel M; Weiss D; Peters M; Wiedenmann B; Schäper F; Stein H; Riecken EO; Foss H
Digestion; 2000; 62(1):60-5. PubMed ID: 10899727
[TBL] [Abstract][Full Text] [Related]
33. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
34. The aberrant intraepithelial T cells in refractory coeliac disease show epidermotropism.
Liu H; Fofaria RK; Greenfield SM; Robson A; Wright P; Isaacson PG; Woodward J; Du MQ
J Clin Pathol; 2014 Apr; 67(4):380-2. PubMed ID: 24403188
[No Abstract] [Full Text] [Related]
35. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
Chander U; Leeman-Neill RJ; Bhagat G
Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
[TBL] [Abstract][Full Text] [Related]
38. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium.
Halstensen TS; Brandtzaeg P
Eur J Immunol; 1993 Feb; 23(2):505-10. PubMed ID: 8094672
[TBL] [Abstract][Full Text] [Related]
39. Therapy with budesonide in patients with refractory sprue.
Daum S; Ipczynski R; Heine B; Schulzke JD; Zeitz M; Ullrich R
Digestion; 2006; 73(1):60-8. PubMed ID: 16612091
[TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II.
Soderquist CR; Lewis SK; Gru AA; Vlad G; Williams ES; Hsiao S; Mansukhani MM; Park DC; Bacchi CE; Alobeid B; Green PH; Bhagat G
Am J Surg Pathol; 2021 Jul; 45(7):905-916. PubMed ID: 33544565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
